Diuretic Treatment in Heart Failure

Overview

Journal N Engl J Med

Specialty General Medicine

Date 2017 Nov 16

PMID 29141174

Citations 113

Authors

David H Ellison

G Michael Felker

Affiliations

Soon will be listed here.

Citing Articles

Subcutaneous Furosemide Therapy for Chronic Management of Refractory Congestive Heart Failure in Dogs and Cats.

Lombardo S, Ferasin H, Ferasin L Animals (Basel). 2025; 15(3).

PMID: 39943128 PMC: 11815753. DOI: 10.3390/ani15030358.

Pharmacologic Management of Heart Failure with Preserved Ejection Fraction (HFpEF) in Older Adults.

Hashemi A, Kwak M, Goyal P Drugs Aging. 2025; 42(2):95-110.

PMID: 39826050 DOI: 10.1007/s40266-024-01165-2.

Continuous frusemide infusion versus intermittent bolus therapy in paediatric intensive care: A single centre retrospective study.

Preeprem N, See E, Namachivayam S, Gelbart B Crit Care Resusc. 2025; 26(4):319-325.

PMID: 39781487 PMC: 11704154. DOI: 10.1016/j.ccrj.2024.10.001.

Cardiorenal Syndrome in Heart Failure with Preserved Ejection Fraction: Insights into Pathophysiology and Recent Advances.

Khandait H, Sodhi S, Khandekar N, Bhattad V Cardiorenal Med. 2025; 15(1):41-60.

PMID: 39756385 PMC: 11844688. DOI: 10.1159/000542633.

Management of Pediatric Heart Failure.

Dipchand A Korean Circ J. 2024; 54(12):794-810.

PMID: 39733776 PMC: 11685346. DOI: 10.4070/kcj.2024.0320.

References

Grodin J, Stevens S, de las Fuentes L, Kiernan M, Birati E, Gupta D . Intensification of Medication Therapy for Cardiorenal Syndrome in Acute Decompensated Heart Failure. J Card Fail. 2015; 22(1):26-32. PMC: 4706474. DOI: 10.1016/j.cardfail.2015.07.007. View

Vitzthum H, Seniuk A, Schulte L, Muller M, Hetz H, Ehmke H . Functional coupling of renal K+ and Na+ handling causes high blood pressure in Na+ replete mice. J Physiol. 2014; 592(5):1139-57. PMC: 3948568. DOI: 10.1113/jphysiol.2013.266924. View

Faris R, Flather M, Purcell H, Poole-Wilson P, Coats A . Diuretics for heart failure. Cochrane Database Syst Rev. 2012; (2):CD003838. DOI: 10.1002/14651858.CD003838.pub3. View

Raz I, Cahn A . Heart failure: SGLT2 inhibitors and heart failure -- clinical implications. Nat Rev Cardiol. 2016; 13(4):185-6. DOI: 10.1038/nrcardio.2016.35. View

Gheorghiade M, Gattis W, OConnor C, Adams Jr K, Elkayam U, Barbagelata A . Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial. JAMA. 2004; 291(16):1963-71. DOI: 10.1001/jama.291.16.1963. View

Jentzer J, DeWald T, Hernandez A . Combination of loop diuretics with thiazide-type diuretics in heart failure. J Am Coll Cardiol. 2010; 56(19):1527-34. DOI: 10.1016/j.jacc.2010.06.034. View

Yancy C, Jessup M, Bozkurt B, Butler J, Casey Jr D, Drazner M . 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013; 128(16):1810-52. DOI: 10.1161/CIR.0b013e31829e8807. View

Aliti G, Rabelo E, Clausell N, Rohde L, Biolo A, Beck-da-Silva L . Aggressive fluid and sodium restriction in acute decompensated heart failure: a randomized clinical trial. JAMA Intern Med. 2013; 173(12):1058-64. DOI: 10.1001/jamainternmed.2013.552. View

Vargo D, Kramer W, Black P, Smith W, Serpas T, Brater D . Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure. Clin Pharmacol Ther. 1995; 57(6):601-9. DOI: 10.1016/0009-9236(95)90222-8. View

10.

Konstam M, Kiernan M, Chandler A, Dhingra R, Mody F, Eisen H . Short-Term Effects of Tolvaptan in Patients With Acute Heart Failure and Volume Overload. J Am Coll Cardiol. 2017; 69(11):1409-1419. DOI: 10.1016/j.jacc.2016.12.035. View

11.

Costanzo M, Saltzberg M, OSullivan J, Sobotka P . Early ultrafiltration in patients with decompensated heart failure and diuretic resistance. J Am Coll Cardiol. 2005; 46(11):2047-51. DOI: 10.1016/j.jacc.2005.05.099. View

12.

Gheorghiade M, Follath F, Ponikowski P, Barsuk J, Blair J, Cleland J . Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care.... Eur J Heart Fail. 2010; 12(5):423-33. DOI: 10.1093/eurjhf/hfq045. View

13.

Pang P, Konstam M, Krasa H, Swedberg K, Zannad F, Blair J . Effects of tolvaptan on dyspnoea relief from the EVEREST trials. Eur Heart J. 2009; 30(18):2233-40. PMC: 2742783. DOI: 10.1093/eurheartj/ehp253. View

14.

Peixoto A, Alpern R . Treatment of severe metabolic alkalosis in a patient with congestive heart failure. Am J Kidney Dis. 2013; 61(5):822-7. DOI: 10.1053/j.ajkd.2012.10.028. View

15.

Francis G, Siegel R, Goldsmith S, Olivari M, Levine T, Cohn J . Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis. Ann Intern Med. 1985; 103(1):1-6. DOI: 10.7326/0003-4819-103-1-1. View

16.

Knauf H, Mutschler E . Low-dose segmental blockade of the nephron rather than high-dose diuretic monotherapy. Eur J Clin Pharmacol. 1993; 44 Suppl 1:S63-8. DOI: 10.1007/BF01428397. View

17.

Vallon V, Rieg T, Ahn S, Wu W, Eraly S, Nigam S . Overlapping in vitro and in vivo specificities of the organic anion transporters OAT1 and OAT3 for loop and thiazide diuretics. Am J Physiol Renal Physiol. 2008; 294(4):F867-73. DOI: 10.1152/ajprenal.00528.2007. View

18.

Gandhi S, Mosleh W, Myers R . Hypertonic saline with furosemide for the treatment of acute congestive heart failure: a systematic review and meta-analysis. Int J Cardiol. 2014; 173(2):139-45. DOI: 10.1016/j.ijcard.2014.03.020. View

19.

Schwartzenberg S, Redfield M, From A, Sorajja P, Nishimura R, Borlaug B . Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy. J Am Coll Cardiol. 2012; 59(5):442-51. DOI: 10.1016/j.jacc.2011.09.062. View

20.

Felker G, Mentz R, Cole R, Adams K, Egnaczyk G, Fiuzat M . Efficacy and Safety of Tolvaptan in Patients Hospitalized With Acute Heart Failure. J Am Coll Cardiol. 2016; 69(11):1399-1406. DOI: 10.1016/j.jacc.2016.09.004. View